2025 HCPCS Code J7608
Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
TAGS: inhalation administered final through| Short Description | Acetylcysteine non-comp unit |
| Product Note | 0135 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2000 |
| HCPCS Action Effective Date | January 01, 2008 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J0690 - Cefazolin sodium injection
- J0691 - Inj lefamulin 1 mg
- J0692 - Cefepime hcl for injection
- J0693 - Inj., cefiderocol, 5 mg
- J0694 - Cefoxitin sodium injection
- J0695 - Inj ceftolozane tazobactam
- J0696 - Ceftriaxone sodium injection
- J0697 - Sterile cefuroxime injection
- J0698 - Cefotaxime sodium injection
- J0699 - Inj, cefiderocol, 10 mg
- J0701 - Inj. cefepime hcl (baxter)
- J0702 - Betamethasone acet&sod phosp
- J0703 - Inj, cefepime hcl (b braun)
- J0706 - Caffeine citrate injection
- J0710 - Cephapirin sodium injection
- J0712 - Ceftaroline fosamil inj
- J0713 - Inj ceftazidime per 500 mg
- J0714 - Ceftazidime and avibactam
- J0715 - Ceftizoxime sodium / 500 mg
- J0716 - Centruroides immune f(ab)